| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/14/2013 | US20130064821 Methods and compositions for treating prostate cancer |
| 03/14/2013 | US20130064820 Methods and compositions for treating degos' disease |
| 03/14/2013 | US20130064818 Use of immunesuppressant receptor |
| 03/14/2013 | US20130064816 TNF-alpha ANTAGONISTS AND METHOTREXATE IN THE TREATMENT OF TNF-MEDIATED DISEASE |
| 03/14/2013 | US20130064813 Protein Belonging to the TNF Superfamily Involved in Signal Transduction, Nucleic Acids Encoding Same and Methods of Use Thereof |
| 03/14/2013 | US20130064809 Antimicrobial Composition and Uses Thereof |
| 03/14/2013 | US20130064807 Use of thrombin mutants to inhibit the anticoagulation effect of thrombin inhibitors |
| 03/14/2013 | US20130064806 Novel pharmaceutical salts and polymorphs of a factor xa inhibitor |
| 03/14/2013 | US20130064805 Highly functional enzyme having alpha-galactosidase activity |
| 03/14/2013 | US20130064804 BIO-REPLENISHMENT (BioRep) FOR IMPROVING SLEEP ARCHITECTURE |
| 03/14/2013 | US20130064803 BIO-REPLENISHMENT (BioRep) FOR COGNITIVE HEALTH |
| 03/14/2013 | US20130064794 Substituted Carbonyloxymethylphosphoramidate Compounds and Pharmaceutical Compositions for the Treatment of Viral Infections |
| 03/14/2013 | US20130064793 Compounds and pharmaceutical compositions for the treatment of viral infections |
| 03/14/2013 | US20130064792 Therapy for influenza like illness |
| 03/14/2013 | US20130064791 Interferon Analogs |
| 03/14/2013 | US20130064790 Peptides with the capacity to bind to interleukin-10 (il-10) |
| 03/14/2013 | US20130064788 Il-17 family cytokine compositions and uses |
| 03/14/2013 | US20130064787 Methods for Treatment of HIV and Other Infections Using a T Cell or Viral Activator and Anti-Retroviral Combination Therapy |
| 03/14/2013 | US20130064786 siRNA HYDROGEL AND METHOD FOR MANUFACTURING THE SAME |
| 03/14/2013 | US20130064774 Methods and compositions for maintenance of a functional wound |
| 03/14/2013 | US20130064765 Antithrombotic nanoparticle |
| 03/14/2013 | US20130064761 Methods for the treatment of tumors expressing TAT123 or naturally occurring variants thereof |
| 03/14/2013 | US20130064760 Method for Treating Crohn's Disease By Administering An Anti-IL-12 Antibody |
| 03/14/2013 | CA2849448A1 Oral delivery for hemoglobin based oxygen carriers |
| 03/14/2013 | CA2848118A1 Endostatin mutants with mutations at atp binding sites |
| 03/14/2013 | CA2847888A1 Methods and compositions for controlling assembly of viral proteins |
| 03/14/2013 | CA2847862A1 Compstatin analogs with improved pharmacokinetic properties |
| 03/14/2013 | CA2847837A1 A pharmaceutical composition for treating cancer, comprising interferon alpha conjugate |
| 03/14/2013 | CA2847555A1 Materials and methods for modulating immune responses |
| 03/14/2013 | CA2846511A1 Treatment of allodynia, hyperalgsia, spontaneous pain, and phantom pain |
| 03/13/2013 | EP2567983A1 Tumor-targeted tumor necrosis factor-related apoptosis ligand variant and use thereof |
| 03/13/2013 | EP2567968A1 Polypeptides targeting glycosylated Muc2 proteins, methods of synthesis, their nucleic acids and uses therof |
| 03/13/2013 | EP2567707A2 Composition of tumour-associated peptides and related anti-cancer vaccine |
| 03/13/2013 | EP2567706A2 Peptide sequences and compositions |
| 03/13/2013 | EP2567705A2 Methods of treating cognitive dysfunction by modulating brain energy metabolism |
| 03/13/2013 | EP2566972A1 Compositions for linking zinc finger modules |
| 03/13/2013 | EP2566967A1 Detection and treatment of fibrosis |
| 03/13/2013 | EP2566965A2 Antagonists of sema3e/plexind1 interaction as anti-cancer agents |
| 03/13/2013 | EP2566882A1 Agents for treating alzheimer's disease |
| 03/13/2013 | EP2566880A1 Aromatic-cationic peptides and uses of same |
| 03/13/2013 | EP2566878A1 Methods of inhibiting inflammation and inflammatory diseases using gal-3bp (btbd17b, lgals3bp, galectin-3 binding protein, mac-2 binding protein) |
| 03/13/2013 | EP2566519A2 Staphylococcus aureus leukocidins, therapeutic compositions, and uses thereof |
| 03/13/2013 | EP2566518A1 Dendritic cell immunoreceptors (dcir)-mediated crosspriming of human cd8+ t cells |
| 03/13/2013 | EP2566516A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of seryl-trna synthetases |
| 03/13/2013 | EP2566515A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of arginyl-trna synthetases |
| 03/13/2013 | EP2566513A1 Gfi1b modulation and uses thereof |
| 03/13/2013 | EP2566505A1 Delivery of cholesteryl ester to steroidogenic tissues |
| 03/13/2013 | EP2566504A2 New emd formulation comprising pga |
| 03/13/2013 | EP2566503A1 Therapeutic peptide composition and method |
| 03/13/2013 | EP2566502A1 Methods for treating or preventing cardiovascular disorders and providing cardiovascular protection |
| 03/13/2013 | EP2566501A2 Method and device for transdermal delivery of parathyroid hormone using a microprojection array |
| 03/13/2013 | EP2566500A2 Use of ccl1 in therapy |
| 03/13/2013 | EP2566499A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-trna synthetase complex |
| 03/13/2013 | EP2566498A1 Compounds, medicaments and methods of treatment for helicobacter pylori infection. |
| 03/13/2013 | EP2566497A1 Biocatalysts for ezetimibe synthesis |
| 03/13/2013 | EP2566496A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-trna synthetases |
| 03/13/2013 | EP2566495A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-trna synthetases |
| 03/13/2013 | EP2566494A2 Cxcr4 receptor compounds |
| 03/13/2013 | EP2566493A1 Bifunctional molecules for inactivating hiv and blocking hiv |
| 03/13/2013 | EP2566492A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutamyl-prolyl-trna synthetases |
| 03/13/2013 | EP2566484A2 Compositions containing purine and pyrimidine nucleosides, peptides, and manganese and their uses |
| 03/13/2013 | EP2566483A1 Methods and agents for enhancing wound healing |
| 03/13/2013 | EP2566469A1 Combination therapy |
| 03/13/2013 | EP2407536A9 ADP-ribosyl transferase fusion variant proteins |
| 03/13/2013 | CN202776947U Scraping plate device with liquid storage bottle |
| 03/13/2013 | CN1984672B Modulation of NKG2D |
| 03/13/2013 | CN1578785B Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 03/13/2013 | CN102971336A Peptide for use as a medicament, in particular for the treatment of cancer |
| 03/13/2013 | CN102971013A Conjugated blood coagulation factor VIIa |
| 03/13/2013 | CN102971006A Stabilized factor VIII variants |
| 03/13/2013 | CN102971005A Diabetes therapy |
| 03/13/2013 | CN102971004A Compounds, medicaments and methods of treatment for helicobacter pylori infection. |
| 03/13/2013 | CN102971003A Improved cancer therapy based on tumor associated antigens derived from cyclin D1 |
| 03/13/2013 | CN102971002A Composition for nucleic acid delivery, carrier composition, pharmaceutical composition using the composition for nucleic acid delivery or the carrier composition, and method for delivering nucleic acid |
| 03/13/2013 | CN102971001A Methods of treating cancer using growth factor retargeted endopeptidases |
| 03/13/2013 | CN102970975A Method for preparing an enriched IgG composition from plasma |
| 03/13/2013 | CN102965418A Extraction method for biological oat polypeptide and applications thereof |
| 03/13/2013 | CN102964442A Method for preparing polyethylene glycol (PEG) and nerve growth factor (NGF) conjugate |
| 03/13/2013 | CN102964427A Bioactive polypeptide QEPVL, and preparation and application thereof |
| 03/13/2013 | CN102964426A Tumor antigens for prevention and/or treatment of cancer |
| 03/13/2013 | CN102964425A Conjugates of Docetaxel and simplified MDP analogue and anti-tumor effect |
| 03/13/2013 | CN102964422A Method for preparing antioxidant peptide by utilizing ox hair |
| 03/13/2013 | CN102961739A Application of KLOTHO protein |
| 03/13/2013 | CN102961738A Pilose antler polypeptide external preparation and production process thereof |
| 03/13/2013 | CN102961737A Application of polypeptide DZ24 in preparation of medicine for treating goat bacteria or fungal inflammation |
| 03/13/2013 | CN102961736A Application of goat antibacterial peptide GC41 |
| 03/13/2013 | CN102961735A Application of regulatory peptides GM21 in preparation of medicine for adjusting goat immune function |
| 03/13/2013 | CN102961734A Coccidiosis-resisting growth-promoting compound preparation and preparation method thereof |
| 03/13/2013 | CN102961733A Application of seaweed polypeptide in preparing health-care product for reducing blood fat and blood sugar as well as beverage containing polypeptide for reducing blood fat and blood sugar |
| 03/13/2013 | CN102961732A Composition for treating rabbit enteritis and preparation method thereof |
| 03/13/2013 | CN102961440A Pharmaceutical composition containing cyclooxygenase and natural doxorubicin or doxorubicin-like substances, its preparation method and application in preparation of multiple drugs |
| 03/13/2013 | CN102961359A Lumbrukinase enteric-coated pellet capsule and preparation method thereof |
| 03/13/2013 | CN102961340A Nanoscale insulin and preparation method thereof |
| 03/13/2013 | CN102961334A Method for preparing stable chicken alpha interferon spray preparation |
| 03/13/2013 | CN102961324A Gel for lysozyme eye and preparation method thereof |
| 03/13/2013 | CN102960444A Preparation method of goat milk containing ACE (Angiotensin Converting Enzyme) inhibitory peptide based on Lactobacillus helveticus fermentation |
| 03/13/2013 | CN102228683B Method for preparing freeze-dried human blood coagulation factor VIII |
| 03/13/2013 | CN102206264B O.jingdongensis sp. antibacterial peptide and preparation method and use thereof |
| 03/13/2013 | CN102188691B Application of tachyplesin in preparing antihrombotic medicines and health-care products and preparation method thereof |
| 03/13/2013 | CN102172406B Intact minicells as vectors for DNA transfer and gene therapy in vitro and in vivo |